Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine

Ribonucleotide reductase subunits M1 (RRM1) and M2 (RRM2) are involved in the metabolism of gemcitabine (2′,2′-difluorodeoxycytidine), which is used for the treatment of nonsmall cell lung cancer. The mRNA expression of RRM1 and RRM2 in tumours from lung adenocarcinoma patients treated with docetaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Souglakos, J, Boukovinas, I, Taron, M, Mendez, P, Mavroudis, D, Tripaki, M, Hatzidaki, D, Koutsopoulos, A, Stathopoulos, E, Georgoulias, V, Rosell, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391126/
https://www.ncbi.nlm.nih.gov/pubmed/18414411
http://dx.doi.org/10.1038/sj.bjc.6604344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391126/
https://www.ncbi.nlm.nih.gov/pubmed/18414411
http://dx.doi.org/10.1038/sj.bjc.6604344

Ejemplares similares